Comparison of mHTT Antibodies in Huntington's Disease Mouse Models Reveal Specific Binding Profiles and Steady-State Ubiquitin Levels with Disease Development.

Comparison of mHTT Antibodies in Huntington's Disease Mouse Models Reveal Specific Binding Profiles and Steady-State Ubiquitin Levels with Disease Development.

Huntington's disease (HD) cellular pathology is characterised by the aggregation of mutant huntingtin (mHTT) protein into inclusion bodies. The present paper compared the sensitivity of five widely used mHTT antibodies (S830; MW8; EM48; 1C2; ubiquitin) against mice from five commonly used HD mo...

Full description

Bibliographic Details
Main Authors:	Zubeyde Bayram-Weston, Lesley Jones, Stephen B Dunnett, Simon P Brooks
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0155834&type=printable

Similar Items

Reduction in PA28αβ activation in HD mouse brain correlates to increased mHTT aggregation in cell models.
by: Karlijne W Geijtenbeek, et al.
Published: (2022-01-01)

Formation of hippocampal mHTT aggregates leads to impaired spatial memory, hippocampal activation and adult neurogenesis
by: LC Schwab, et al.
Published: (2017-06-01)

Genome-wide In Vivo CNS Screening Identifies Genes that Modify CNS Neuronal Survival and mHTT Toxicity
by: Wertz, Mary H, et al.
Published: (2021)

A novel and accurate full-length HTT mouse model for Huntington’s disease
by: Sushila A Shenoy, et al.
Published: (2022-01-01)

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
by: Sathasivam, Kirupa, et al.
Published: (2013)

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
by: Sathasivam, Kirupa, et al.
Published: (2013)

Huntington’s Disease—An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components
by: Aleksandra S. Taran, et al.
Published: (2020-06-01)

In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease
by: Harleen Kohli, et al.
Published: (2021-02-01)

Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT
by: Cesar L. Moreno, et al.
Published: (2016-01-01)

The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
by: Andreas Neueder, et al.
Published: (2017-05-01)

Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease.
by: Sydney R Coffey, et al.
Published: (2017-01-01)

AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
by: Elisabeth A. Spronck, et al.
Published: (2019-06-01)

Integrated analysis on transcriptome and behaviors defines HTT repeat-dependent network modules in Huntington's disease
by: Lulin Huang, et al.
Published: (2022-03-01)

Functional Characterisation of the Circular RNA, <i>circHTT(2-6)</i>, in Huntington’s Disease
by: Laura Gantley, et al.
Published: (2023-05-01)

Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease
by: Bardile, Costanza Ferrari, et al.
Published: (2020)

An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington’s disease patient neurons
by: Florian Krach, et al.
Published: (2022-11-01)

Parkinsonism with a Hint of Huntington’s from 29 CAG Repeats in HTT
by: Sipilä JOT
Published: (2019-09-01)

The Ubiquitin-Proteasome Pathway in Huntington's Disease
by: Siddhartha Mitra, et al.
Published: (2008-01-01)

Ubiquitin-modifying enzymes in Huntington’s disease
by: Karen A. Sap, et al.
Published: (2023-02-01)

Strategies to Investigate Ubiquitination in Huntington's Disease
by: Karen A. Sap, et al.
Published: (2020-06-01)

A Longitudinal Operant Assessment of Cognitive and Behavioural Changes in the HdhQ111 Mouse Model of Huntington's Disease.
by: Emma Yhnell, et al.
Published: (2016-01-01)

Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington's disease: an in vivo high-content imaging study.
by: Nikisha Carty, et al.
Published: (2015-01-01)

Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease Pathology
by: Elisabeth A. Spronck, et al.
Published: (2021-01-01)

Atypical course of Parkinson’s disease with clinical manifestations of Huntington’s disease in a patient with an allele of 27 CAG repeats in the HTT gene
by: M. A. Nikitina, et al.
Published: (2021-01-01)

Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the httQ140/Q140 mouse model of Huntington's disease
by: Robyn L. McAdam, et al.
Published: (2020-02-01)

Ubiquitin-proteasome system involvement in Huntington’s disease
by: Zaira eOrtega, et al.
Published: (2014-09-01)

Identification of a HTT-specific binding motif in DNAJB1 essential for suppression and disaggregation of HTT
by: S. M. Ayala Mariscal, et al.
Published: (2022-08-01)

Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice
by: Elsa C. Kuijper, et al.
Published: (2024-01-01)

Excess Rab4 rescues synaptic and behavioral dysfunction caused by defective HTT-Rab4 axonal transport in Huntington’s disease
by: Joseph A. White, et al.
Published: (2020-07-01)

Generation of an induced pluripotent stem cell line from a Huntington’s disease patient with a long HTT-PolyQ sequence
by: Duncan C. Miller, et al.
Published: (2023-04-01)

Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease‐affected families
by: Thays A. Apolinário, et al.
Published: (2020-04-01)

The Ubiquitin-Proteasome System in Huntington’s Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue?
by: Sabine Schipper-Krom, et al.
Published: (2012-01-01)

Comment on: “Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease‐affected families.”
by: Gustavo L. Franklin, et al.
Published: (2020-06-01)

Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington’s disease
by: Jaisan Islam, et al.
Published: (2021-11-01)

The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington's disease.
by: John S Bett, et al.
Published: (2009-01-01)

Gait dynamics in mouse models of Parkinson's disease and Huntington's disease
by: Morgan James P, et al.
Published: (2005-07-01)

Towards a Protocol for the Preparation and Delivery of Striatal Tissue for Clinical Trials of Transplantation in Huntington's Disease
by: Colin Watts, et al.
Published: (2000-03-01)

The Role of Pretraining on Skilled Forelimb Use in an Animal Model of Huntington's Disease
by: R. A. Fricker-Gates, et al.
Published: (2003-04-01)

Hypomorphic mutation of the mouse Huntington's disease gene orthologue.
by: Vidya Murthy, et al.
Published: (2019-03-01)

Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
by: Chen Xi, et al.
Published: (2011-11-01)